Key result
High clinically derived blood pressure variability combined with low heart rate variability significantly increased the risk of incident Alzheimer's Disease and Related Dementias (HR 2.34).
Why the study?
Although blood pressure variability and heart rate variability are linked to dementia in controlled studies, whether they provide predictive value in routine clinical care is unclear.
Does high blood pressure variability and/or low heart rate variability predict incident Alzheimer's Disease and Related Dementias in adults receiving routine clinical care?
Cohort (n=48,204)
No
Does high blood pressure variability and/or low heart rate variability predict incident Alzheimer's Disease and Related Dementias in adults receiving routine clinical care?
Hazard Ratio: 2.34 (95% CI 1.44–3.81)
Clinically derived blood pressure variability, but not heart rate variability, is a consistent and readily available metric for assessing the risk of incident Alzheimer's Disease and Related Dementias in real-world patient care.
Blood pressure variability (BPV) and heart rate variability (HRV) have been associated with Alzheimer's Disease and Related Dementias (ADRD) in rigorously controlled studies. However, the extent to which BPV and HRV may offer predictive information in real-world, routine clinical care is unclear. In a retrospective cohort study of 48,204 adults (age 54.9 ± 17.5 years, 60% female) receiving continuous care at a single center, we derived BPV and HRV from routinely collected clinical data. We use multivariable Cox models to evaluate the association of BPV and HRV, separately and in combination, with incident ADRD. Over a median 3 [2.4, 3.0] years, there were 443 cases of new-onset ADRD. We found that clinically derived measures of BPV, but not HRV, were consistently associated with incident ADRD. In combined analyses, only patients in both the highest quartile of BPV and lowest quartile of HRV had increased ADRD risk (HR 2.34, 95% CI 1.44-3.81). These results indicate that clinically derived BPV, rather than HRV, offers a consistent and readily available metric for ADRD risk assessment in a real-world patient care setting. Thus, implementation of BPV as a widely accessible tool could allow clinical providers to efficiently identify patients most likely to benefit from comprehensive ADRD screening.
No takes yet. Share an insight, caveat, or question.
Ebinger et al. (2024) conducted a cohort in Alzheimer's Disease and Related Dementias (ADRD) (n=48,204). Highest quartile of blood pressure variability and lowest quartile of heart rate variability vs. Lowest quartile of blood pressure variability and highest quartile of heart rate variability was evaluated on Incident Alzheimer's Disease and Related Dementias (ADRD) (HR 2.34, 95% CI 1.44-3.81). High clinically derived blood pressure variability combined with low heart rate variability significantly increased the risk of incident Alzheimer's Disease and Related Dementias (HR 2.34).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: